Updated:
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001544116, and its reported...
Overview
Durata Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001544116, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-03-14, it reported net income of USD -62,141,000; total assets of USD 100,144,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Durata Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Chicago, IL, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001544116
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents |
|---|---|---|---|---|
| FY2013USD | -$62.1M | $100.1M | $36.9M | |
| FY2012USD | -$62.5M | $86.5M | $32.3M |
FY2012. Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Durata Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.